About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 521 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 521 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 521 trials

CompletedQuality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerRATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy.NCT00052481·San Francisco, California and 12 others CompletedA Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)This is a randomized, double-blind, placebo-controlled, multinational Phase 2 study to evaluate and compare oral AT-101 in combination with docetaxel and prednisone versus…NCT00571675·Colorado Springs, Colorado and 34 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateA 2-part, Phase 1-2, open-label, parallel group, randomized study in patients with Castration-Resistant Prostate Cancer (CRPC) who are no longer responding to treatment with…NCT01685268·Los Angeles, California and 31 others

TerminatedLeuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Inserting the gene for interleukin-2 into a person's cancer cells may improve the body's ability to fight cancer.NCT00004050·Los Angeles, California and 1 other

CompletedEfficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.NCT02200614·Homewood, Alabama and 403 others

UnknownGadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerThe purpose of this research study is to test to see if Gadoxetate Sodium is a useful contrast agent for detecting prostate cancer during magnetic resonance imaging (MRI).NCT03960788·Cincinnati, Ohio

TerminatedImproving Erectile Function and Quality of Life After Prostate Cancer TreatmentThis is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study.NCT01996852·Cleveland, Ohio

RecruitingStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy…NCT05519449·Birmingham, Alabama and 35 others

Active not recruitingSpaceIT Hydrogel System for Perirectal SpacingTo evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.NCT06451614·Laguna Hills, California and 25 others

Active not recruitingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsThis research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies among four cohorts, bladder or upper tract carcinoma with…NCT03333616·La Jolla, California and 5 others

CompletedFor Cause Prostate Biopsy in REDUCE Population TrialThe REDUCE trial was conducted to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the…NCT01529086·Cleveland, Ohio

CompletedA Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to HistopathologyThis was a multicenter, multi-reader, open-label, Phase 2 study assessing the safety and performance characteristics of MIP 1404 imaging in the detection of prostate gland and…NCT01667536·Duarte, California and 34 others

CompletedTreatment of Hemorrhagic Radiation Proctitis Using the Halo SystemThis study involves evaluating a procedure in which the study device, the HALO90 Ablation catheter, is used to heat a thin layer of tissue lining the rectum using radiofrequency…NCT01103492·Cleveland, Ohio

CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionThis phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction.NCT01638533·Duarte, California and 11 others

CompletedProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyProvenge is an investigational product designed to activate a man's own antigen presenting cells, a type of immune cell, so that they can detect prostate cancer cells and initiate…NCT00065442·Laguna Hills, California and 70 others

Active not recruitingPhase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed…NCT06691984·Birmingham, Alabama and 163 others

CompletedA Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXThis is a multi-center, prospective, observational study of patients being treated with ORGOVYX.NCT05467176·Homewood, Alabama and 95 others

CompletedOnline Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialThis phase I trial tests the feasibility, acceptability, and preliminary effectiveness of online dietary and resistance training to improve physical function in older (greater…NCT06016725·Columbus, Ohio

Active not recruitingAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryThis randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy and radiation therapy…NCT03070886·Mobile, Alabama and 312 others

TerminatedPII Trial of Docetaxel/Prednisone w/Sargramostim for HRPCThis is a Phase II, open-label study in male patients with metastatic HRPC. Each cycle will be 21 days (3 weeks).NCT00313482·Columbus, Ohio

PreviousPage 17 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma